Literature DB >> 485131

In vitro susceptibilities of Naegleria fowleri strain HB-1 to selected antimicrobial agents, singly and in combination.

K K Lee, S L Karr, M M Wong, P D Hoeprich.   

Abstract

The overall prognosis of primary amoebic meningoencephalitis remains poor. The results of this study support previous finding that amphotericin B is the most efficacious drug against the Naegleria species in in vitro testing. In addition, the methyl ester of amphotericin B, a new derivative, also appears to be an effective agent. Of the drug combinations studied, amphotericin B plus minocycline and amphotericin B plus tetracycline showed synergy. The clinical significance of these findings remains to be determined.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 485131      PMCID： PMC352825          DOI： 10.1128/AAC.16.2.217

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  19 in total

1.  RELEASE OF INTRACELLULAR CONSTITUENTS OF CANDIDA ALBICANS IN PRESENCE OF POLYENE ANTIBIOTICS.

Authors:  A GHOSH; J J GHOSH
Journal:  Ann Biochem Exp Med       Date:  1963-12

2.  Synergistic action of amphotericin B and rifampin on Candida albicans.

Authors:  W H Beggs; G A Sarosi; F A Andrews
Journal:  Am Rev Respir Dis       Date:  1974-11

3.  Letter: Primary amoebic meningoencephalitis.

Authors:  A Jamieson; K Anderson
Journal:  Lancet       Date:  1974-02-16       Impact factor: 79.321

4.  Changes in the virulence of Naegleria fowleri maintained in vitro.

Authors:  M M Wong; S L Karr; C K Chow
Journal:  J Parasitol       Date:  1977-10       Impact factor: 1.276

5.  Growth inhibition of Naegleria fowleri by tetracycline, rifamycin, and miconazole.

Authors:  Y H Thong; B Rowan-Kelly; C Shepherd; A Ferrante
Journal:  Lancet       Date:  1977-10-22       Impact factor: 79.321

6.  Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).

Authors:  G Medoff; G S Kobayashi; C N Kwan; D Schlessinger; P Venkov
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

7.  In vitro susceptibility of pathogenic Naegleria and Acanthamoeba speicies to a variety of therapeutic agents.

Authors:  R J Duma; R Finley
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

8.  Antifungal activity of four tetracycline analogues against Candida albicans in vitro: potentiation by amphotericin B.

Authors:  M A Lew; K M Beckett; M J Levin
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

9.  Synergism between tetracycline and amphotericin B in experimental amoebic meningoencephalitis.

Authors:  Y H Thong; B Rowan-Kelly; C Shepherd; A Ferrante
Journal:  Med J Aust       Date:  1978-06-17       Impact factor: 7.738

10.  Potentiation of the antifungal effects of antibiotics by amphotericin B.

Authors:  C N Kwan; G Medoff; G S Kobayashi; D Schlessinger; H J Raskas
Journal:  Antimicrob Agents Chemother       Date:  1972-08       Impact factor: 5.191
View more
  6 in total

1.  Synergistic activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.

Authors:  Shannon M Soltow; George M Brenner
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

2.  Phenothiazine compounds inhibit in vitro growth of pathogenic free-living amoebae.

Authors:  F L Schuster; N Mandel
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

Review 3.  Naegleria fowleri: pathogenesis, diagnosis, and treatment options.

Authors:  Eddie Grace; Scott Asbill; Kris Virga
Journal:  Antimicrob Agents Chemother       Date:  2015-08-10       Impact factor: 5.191

4.  Activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.

Authors:  Shannon M Goswick; George M Brenner
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

5.  Activity of Auranofin against Multiple Genotypes of Naegleria fowleri and Its Synergistic Effect with Amphotericin B In Vitro.

Authors:  Jose Ignacio Escrig; Hye Jee Hahn; Anjan Debnath
Journal:  ACS Chem Neurosci       Date:  2020-05-26       Impact factor: 4.418

6.  Differential Growth Rates and In Vitro Drug Susceptibility to Currently Used Drugs for Multiple Isolates of Naegleria fowleri.

Authors:  A Cassiopeia Russell; Dennis E Kyle
Journal:  Microbiol Spectr       Date:  2022-02-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.